Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ADMA

ADMA BIOLOGICS (ADMA) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $10.36 +0.3% on the day -29.7% over 12 months 52-week range $7.60 – $20.38

Share price and insider trades

ADMA closeInsider buyInsider sale
510152025NovDecJan 2026FebMarAprMayJunJulAugSepOctEEarnings release filed 2025-11-05EEarnings release filed 2026-01-12EEarnings release filed 2026-02-25EEarnings release filed 2026-05-06EEarnings release filed 2026-08-05Bought $50,624 on 2026-05-27 · Jerrold B GrossmanBought $100,125 on 2026-05-12 · Jerrold B GrossmanBought $100,125 on 2026-05-11 · Jerrold B GrossmanBought $107,730 on 2026-03-06 · Steve ElmsBought $109,690 on 2026-03-05 · Steve ElmsSold $157,800 on 2026-03-09 · Kaitlin M. Kestenberg-messinaSold $318,360 on 2026-03-16 · Adam S GrossmanSold $336,000 on 2025-11-19 · Adam S GrossmanSold $336,000 on 2025-10-24 · Adam S GrossmanSold $337,680 on 2026-02-17 · Adam S GrossmanSold $415,590 on 2025-12-15 · Adam S Grossman
Bought, 12 months$468K
Sold, 12 months$1.9M
Insiders buying2
Insiders selling2

ADMA BIOLOGICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $468K and 2 sold $1.9M of ADMA stock on the open market.

ADMA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1.1M sold (6 trades)Q4 2025Q1 2026: $217K bought (2 trades)$217KQ1 2026: $814K sold (5 trades)Q1 2026Q2 2026: $251K bought (3 trades)$251KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$251K3—0
Q1 2026$217K2$814K5
Q4 2025—0$1.1M6

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit+$2KOn all tracked purchases +0.4%

Summary

Over the past 12 months, 2 ADMA BIOLOGICS, INC. insiders reported open-market purchases totaling $468K, while 2 insiders reported sales totaling $1.9M. Among insiders with enough purchase history to measure, Jerrold B Grossman (Director) has the highest Insider Score at 76. 10 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

ADMA earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 5, 2026 +1.8% None +12.9%S&P -0.4% -4.4%
May 6, 2026 -5.8% None -17.4%S&P +1.1% -5.9%
Feb 25, 2026 -5.2% Sold $338K -2.2%S&P +0.3% -39.1%
Jan 12, 2026 -8.1% Sold $416K -1.4%S&P -0.0% -11.9%
Nov 5, 2025 -0.4% Sold $336K -4.1%S&P -0.7% +41.5%
Aug 6, 2025 +10.7% None -11.7%S&P +0.7% +0.7%
May 7, 2025 +17.7% None -8.3%S&P +1.1% -2.8%
Mar 3, 2025 +1.9% None +3.8%S&P -2.9% +14.3%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
May 28SEC Jerrold B GrossmanDirector Buy 6,400520,284 held (+1%) $7.91 $51K +31.0% 76
May 14SEC Jerrold B GrossmanDirector Buy 12,500513,884 held (+2%) $8.01 $100K +29.3% 76
May 12SEC Jerrold B GrossmanDirector Buy 12,500501,384 held (+3%) $8.01 $100K +29.3% 76
Mar 17SEC Adam S GrossmanCEO, President Sell Plan 15,0002,118,777 held (−1%) $15.16 $227K -31.7% —
Mar 17SEC Adam S GrossmanCEO, President Sell Plan 6,0002,112,777 held (−0%) $15.16 $91K -31.7% —
Mar 10SEC Kaitlin M. Kestenberg-messinaCOO Sell 10,096466,600 held (−2%) $15.63 $158K -33.7% —
Mar 9SEC Steve ElmsDirector Buy 7,0002,038,730 held (+0%) $15.67 $110K -33.9% —
Mar 9SEC Steve ElmsDirector Buy 7,0002,045,730 held (+0%) $15.39 $108K -32.7% —
Feb 17SEC Adam S GrossmanCEO, President Sell Plan 15,0002,290,379 held (−1%) $16.08 $241K -35.6% —
Feb 17SEC Adam S GrossmanCEO, President Sell Plan 6,0002,284,379 held (−0%) $16.08 $96K -35.6% —
Dec 16SEC Adam S GrossmanCEO, President Sell Plan 15,0002,013,850 held (−1%) $19.79 $297K -47.7% —
Dec 16SEC Adam S GrossmanCEO, President Sell Plan 6,0002,007,850 held (−0%) $19.79 $119K -47.7% —
Nov 21SEC Adam S GrossmanCEO, President Sell Plan 15,0002,019,850 held (−1%) $16.00 $240K -35.2% —
Nov 21SEC Adam S GrossmanCEO, President Sell Plan 6,0002,013,850 held (−0%) $16.00 $96K -35.2% —
Oct 24SEC Adam S GrossmanCEO, President Sell Plan 15,0002,025,850 held (−1%) $16.00 $240K -35.2% —
Oct 24SEC Adam S GrossmanCEO, President Sell Plan 6,0002,019,850 held (−0%) $16.00 $96K -35.2% —

Insiders at ADMA BIOLOGICS, INC.

InsiderBoughtSoldLast filingScore
Adam S GrossmanCEO, President — $1.7M Mar 17, 2026 —
Jerrold B GrossmanDirector $251K — May 28, 2026 76
Steve ElmsDirector $217K — Mar 9, 2026 —
Kaitlin M. Kestenberg-messinaCOO — $158K Mar 10, 2026 —

ADMA stock: common questions

Are ADMA BIOLOGICS, INC. insiders buying ADMA stock?

In the past 12 months, 2 insiders reported open-market purchases of ADMA worth $468K. The latest was Director Jerrold B Grossman bought $51K of ADMA at $7.91.

Are ADMA BIOLOGICS, INC. insiders selling ADMA stock?

2 insiders reported sales worth $1.9M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ADMA's 52-week range?

Over the past year ADMA has traded between $7.60 and $20.38. It last closed at $10.36 on Oct 9, 2026.